Get Real Time Here
| Open0.430 | Close0.440 |
| Vol / Avg.48.830K / 167.289K | Mkt Cap35.861M |
| Day Range0.410 - 0.463 | 52 Wk Range0.405 - 1.050 |
vTv Therapeutics Stock (NASDAQ:VTVT), Quotes and News Summary
vTv Therapeutics Stock (NASDAQ: VTVT) stock price, news, charts, stock research, profile.
| Open0.430 | Close0.440 |
| Vol / Avg.48.830K / 167.289K | Mkt Cap35.861M |
| Day Range0.410 - 0.463 | 52 Wk Range0.405 - 1.050 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.070 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-03-07 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 6.00 |
| 2022-08-17 | Northland Capital Markets | Carl Byrnes | Maintains | Outperform | Raises | 1.50 | 2.00 |
| 2022-02-18 | Cantor Fitzgerald | Charles Duncan | Initiates Coverage On | Overweight | Announces | - | 5.00 |
| 2020-02-10 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Raises | 5.00 | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| VTVT | vTv Therapeutics | 2.61% | 35.9M |
| CNTB | Connect Biopharma Hldgs | 11.66% | 40.1M |
| PHXM | PHAXIAM Therapeutics | -8.6% | 30M |
| ALGS | Aligos Therapeutics | -4.28% | 33.1M |
| NCNA | NuCana | 0% | 32.5M |
How do I buy vTv Therapeutics (VTVT) stock?
You can purchase shares of vTv Therapeutics (NASDAQ: VTVT) through any online brokerage.
Who are vTv Therapeutics's (VTVT) competitors?
Other companies in vTv Therapeutics’s space includes: Connect Biopharma Hldgs (NASDAQ:CNTB), PHAXIAM Therapeutics (NASDAQ:PHXM), Aligos Therapeutics (NASDAQ:ALGS), NuCana (NASDAQ:NCNA) and Alaunos Therapeutics (NASDAQ:TCRT).
What is the target price for vTv Therapeutics (VTVT) stock?
The latest price target for vTv Therapeutics (NASDAQ: VTVT) was reported by HC Wainwright & Co. on Tuesday, March 7, 2023. The analyst firm set a price target for 6.00 expecting VTVT to rise to within 12 months (a possible 1263.33% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for vTv Therapeutics (VTVT)?
The stock price for vTv Therapeutics (NASDAQ: VTVT) is $0.4401 last updated September 22, 2023 at 7:59 PM UTC.
Does vTv Therapeutics (VTVT) pay a dividend?
There is no dividend information for vTv Therapeutics.
When is vTv Therapeutics (NASDAQ:VTVT) reporting earnings?
vTv Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is vTv Therapeutics (VTVT) going to split?
There is no upcoming split for vTv Therapeutics.
What sector and industry does vTv Therapeutics (VTVT) operate in?
vTv Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
vTv Therapeutics Stock (NASDAQ:VTVT), Quotes and News Summary
vTv Therapeutics Stock (NASDAQ: VTVT) stock price, news, charts, stock research, profile.
| Open0.430 | Close0.440 |
| Vol / Avg.48.830K / 167.289K | Mkt Cap35.861M |
| Day Range0.410 - 0.463 | 52 Wk Range0.405 - 1.050 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.070 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-03-07 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 6.00 |
| 2022-08-17 | Northland Capital Markets | Carl Byrnes | Maintains | Outperform | Raises | 1.50 | 2.00 |
| 2022-02-18 | Cantor Fitzgerald | Charles Duncan | Initiates Coverage On | Overweight | Announces | - | 5.00 |
| 2020-02-10 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Raises | 5.00 | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| VTVT | vTv Therapeutics | 2.61% | 35.9M |
| CNTB | Connect Biopharma Hldgs | 11.66% | 40.1M |
| PHXM | PHAXIAM Therapeutics | -8.6% | 30M |
| ALGS | Aligos Therapeutics | -4.28% | 33.1M |
| NCNA | NuCana | 0% | 32.5M |
How do I buy vTv Therapeutics (VTVT) stock?
You can purchase shares of vTv Therapeutics (NASDAQ: VTVT) through any online brokerage.
Who are vTv Therapeutics's (VTVT) competitors?
Other companies in vTv Therapeutics’s space includes: Connect Biopharma Hldgs (NASDAQ:CNTB), PHAXIAM Therapeutics (NASDAQ:PHXM), Aligos Therapeutics (NASDAQ:ALGS), NuCana (NASDAQ:NCNA) and Alaunos Therapeutics (NASDAQ:TCRT).
What is the target price for vTv Therapeutics (VTVT) stock?
The latest price target for vTv Therapeutics (NASDAQ: VTVT) was reported by HC Wainwright & Co. on Tuesday, March 7, 2023. The analyst firm set a price target for 6.00 expecting VTVT to rise to within 12 months (a possible 1263.33% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for vTv Therapeutics (VTVT)?
The stock price for vTv Therapeutics (NASDAQ: VTVT) is $0.4401 last updated September 22, 2023 at 7:59 PM UTC.
Does vTv Therapeutics (VTVT) pay a dividend?
There is no dividend information for vTv Therapeutics.
When is vTv Therapeutics (NASDAQ:VTVT) reporting earnings?
vTv Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is vTv Therapeutics (VTVT) going to split?
There is no upcoming split for vTv Therapeutics.
What sector and industry does vTv Therapeutics (VTVT) operate in?
vTv Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
vTv Therapeutics Stock (NASDAQ:VTVT), Quotes and News Summary
vTv Therapeutics Stock (NASDAQ: VTVT) stock price, news, charts, stock research, profile.
| Open0.430 | Close0.440 |
| Vol / Avg.48.830K / 167.289K | Mkt Cap35.861M |
| Day Range0.410 - 0.463 | 52 Wk Range0.405 - 1.050 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.070 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-03-07 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 6.00 |
| 2022-08-17 | Northland Capital Markets | Carl Byrnes | Maintains | Outperform | Raises | 1.50 | 2.00 |
| 2022-02-18 | Cantor Fitzgerald | Charles Duncan | Initiates Coverage On | Overweight | Announces | - | 5.00 |
| 2020-02-10 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Raises | 5.00 | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| VTVT | vTv Therapeutics | 2.61% | 35.9M |
| CNTB | Connect Biopharma Hldgs | 11.66% | 40.1M |
| PHXM | PHAXIAM Therapeutics | -8.6% | 30M |
| ALGS | Aligos Therapeutics | -4.28% | 33.1M |
| NCNA | NuCana | 0% | 32.5M |
How do I buy vTv Therapeutics (VTVT) stock?
You can purchase shares of vTv Therapeutics (NASDAQ: VTVT) through any online brokerage.
Who are vTv Therapeutics's (VTVT) competitors?
Other companies in vTv Therapeutics’s space includes: Connect Biopharma Hldgs (NASDAQ:CNTB), PHAXIAM Therapeutics (NASDAQ:PHXM), Aligos Therapeutics (NASDAQ:ALGS), NuCana (NASDAQ:NCNA) and Alaunos Therapeutics (NASDAQ:TCRT).
What is the target price for vTv Therapeutics (VTVT) stock?
The latest price target for vTv Therapeutics (NASDAQ: VTVT) was reported by HC Wainwright & Co. on Tuesday, March 7, 2023. The analyst firm set a price target for 6.00 expecting VTVT to rise to within 12 months (a possible 1263.33% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for vTv Therapeutics (VTVT)?
The stock price for vTv Therapeutics (NASDAQ: VTVT) is $0.4401 last updated September 22, 2023 at 7:59 PM UTC.
Does vTv Therapeutics (VTVT) pay a dividend?
There is no dividend information for vTv Therapeutics.
When is vTv Therapeutics (NASDAQ:VTVT) reporting earnings?
vTv Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is vTv Therapeutics (VTVT) going to split?
There is no upcoming split for vTv Therapeutics.
What sector and industry does vTv Therapeutics (VTVT) operate in?
vTv Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
vTv Therapeutics Stock (NASDAQ:VTVT), Quotes and News Summary
vTv Therapeutics Stock (NASDAQ: VTVT) stock price, news, charts, stock research, profile.
| Open0.430 | Close0.440 |
| Vol / Avg.48.830K / 167.289K | Mkt Cap35.861M |
| Day Range0.410 - 0.463 | 52 Wk Range0.405 - 1.050 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.070 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-03-07 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 6.00 |
| 2022-08-17 | Northland Capital Markets | Carl Byrnes | Maintains | Outperform | Raises | 1.50 | 2.00 |
| 2022-02-18 | Cantor Fitzgerald | Charles Duncan | Initiates Coverage On | Overweight | Announces | - | 5.00 |
| 2020-02-10 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Raises | 5.00 | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| VTVT | vTv Therapeutics | 2.61% | 35.9M |
| CNTB | Connect Biopharma Hldgs | 11.66% | 40.1M |
| PHXM | PHAXIAM Therapeutics | -8.6% | 30M |
| ALGS | Aligos Therapeutics | -4.28% | 33.1M |
| NCNA | NuCana | 0% | 32.5M |
How do I buy vTv Therapeutics (VTVT) stock?
You can purchase shares of vTv Therapeutics (NASDAQ: VTVT) through any online brokerage.
Who are vTv Therapeutics's (VTVT) competitors?
Other companies in vTv Therapeutics’s space includes: Connect Biopharma Hldgs (NASDAQ:CNTB), PHAXIAM Therapeutics (NASDAQ:PHXM), Aligos Therapeutics (NASDAQ:ALGS), NuCana (NASDAQ:NCNA) and Alaunos Therapeutics (NASDAQ:TCRT).
What is the target price for vTv Therapeutics (VTVT) stock?
The latest price target for vTv Therapeutics (NASDAQ: VTVT) was reported by HC Wainwright & Co. on Tuesday, March 7, 2023. The analyst firm set a price target for 6.00 expecting VTVT to rise to within 12 months (a possible 1263.33% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for vTv Therapeutics (VTVT)?
The stock price for vTv Therapeutics (NASDAQ: VTVT) is $0.4401 last updated September 22, 2023 at 7:59 PM UTC.
Does vTv Therapeutics (VTVT) pay a dividend?
There is no dividend information for vTv Therapeutics.
When is vTv Therapeutics (NASDAQ:VTVT) reporting earnings?
vTv Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is vTv Therapeutics (VTVT) going to split?
There is no upcoming split for vTv Therapeutics.
What sector and industry does vTv Therapeutics (VTVT) operate in?
vTv Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
vTv Therapeutics Stock (NASDAQ:VTVT), Quotes and News Summary
vTv Therapeutics Stock (NASDAQ: VTVT) stock price, news, charts, stock research, profile.
| Open0.430 | Close0.440 |
| Vol / Avg.48.830K / 167.289K | Mkt Cap35.861M |
| Day Range0.410 - 0.463 | 52 Wk Range0.405 - 1.050 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.070 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-03-07 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 6.00 |
| 2022-08-17 | Northland Capital Markets | Carl Byrnes | Maintains | Outperform | Raises | 1.50 | 2.00 |
| 2022-02-18 | Cantor Fitzgerald | Charles Duncan | Initiates Coverage On | Overweight | Announces | - | 5.00 |
| 2020-02-10 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Raises | 5.00 | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| VTVT | vTv Therapeutics | 2.61% | 35.9M |
| CNTB | Connect Biopharma Hldgs | 11.66% | 40.1M |
| PHXM | PHAXIAM Therapeutics | -8.6% | 30M |
| ALGS | Aligos Therapeutics | -4.28% | 33.1M |
| NCNA | NuCana | 0% | 32.5M |
How do I buy vTv Therapeutics (VTVT) stock?
You can purchase shares of vTv Therapeutics (NASDAQ: VTVT) through any online brokerage.
Who are vTv Therapeutics's (VTVT) competitors?
Other companies in vTv Therapeutics’s space includes: Connect Biopharma Hldgs (NASDAQ:CNTB), PHAXIAM Therapeutics (NASDAQ:PHXM), Aligos Therapeutics (NASDAQ:ALGS), NuCana (NASDAQ:NCNA) and Alaunos Therapeutics (NASDAQ:TCRT).
What is the target price for vTv Therapeutics (VTVT) stock?
The latest price target for vTv Therapeutics (NASDAQ: VTVT) was reported by HC Wainwright & Co. on Tuesday, March 7, 2023. The analyst firm set a price target for 6.00 expecting VTVT to rise to within 12 months (a possible 1263.33% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for vTv Therapeutics (VTVT)?
The stock price for vTv Therapeutics (NASDAQ: VTVT) is $0.4401 last updated September 22, 2023 at 7:59 PM UTC.
Does vTv Therapeutics (VTVT) pay a dividend?
There is no dividend information for vTv Therapeutics.
When is vTv Therapeutics (NASDAQ:VTVT) reporting earnings?
vTv Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is vTv Therapeutics (VTVT) going to split?
There is no upcoming split for vTv Therapeutics.
What sector and industry does vTv Therapeutics (VTVT) operate in?
vTv Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
vTv Therapeutics Stock (NASDAQ:VTVT), Quotes and News Summary
vTv Therapeutics Stock (NASDAQ: VTVT) stock price, news, charts, stock research, profile.
| Open0.430 | Close0.440 |
| Vol / Avg.48.830K / 167.289K | Mkt Cap35.861M |
| Day Range0.410 - 0.463 | 52 Wk Range0.405 - 1.050 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.070 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-03-07 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 6.00 |
| 2022-08-17 | Northland Capital Markets | Carl Byrnes | Maintains | Outperform | Raises | 1.50 | 2.00 |
| 2022-02-18 | Cantor Fitzgerald | Charles Duncan | Initiates Coverage On | Overweight | Announces | - | 5.00 |
| 2020-02-10 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Raises | 5.00 | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| VTVT | vTv Therapeutics | 2.61% | 35.9M |
| CNTB | Connect Biopharma Hldgs | 11.66% | 40.1M |
| PHXM | PHAXIAM Therapeutics | -8.6% | 30M |
| ALGS | Aligos Therapeutics | -4.28% | 33.1M |
| NCNA | NuCana | 0% | 32.5M |
How do I buy vTv Therapeutics (VTVT) stock?
You can purchase shares of vTv Therapeutics (NASDAQ: VTVT) through any online brokerage.
Who are vTv Therapeutics's (VTVT) competitors?
Other companies in vTv Therapeutics’s space includes: Connect Biopharma Hldgs (NASDAQ:CNTB), PHAXIAM Therapeutics (NASDAQ:PHXM), Aligos Therapeutics (NASDAQ:ALGS), NuCana (NASDAQ:NCNA) and Alaunos Therapeutics (NASDAQ:TCRT).
What is the target price for vTv Therapeutics (VTVT) stock?
The latest price target for vTv Therapeutics (NASDAQ: VTVT) was reported by HC Wainwright & Co. on Tuesday, March 7, 2023. The analyst firm set a price target for 6.00 expecting VTVT to rise to within 12 months (a possible 1263.33% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for vTv Therapeutics (VTVT)?
The stock price for vTv Therapeutics (NASDAQ: VTVT) is $0.4401 last updated September 22, 2023 at 7:59 PM UTC.
Does vTv Therapeutics (VTVT) pay a dividend?
There is no dividend information for vTv Therapeutics.
When is vTv Therapeutics (NASDAQ:VTVT) reporting earnings?
vTv Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is vTv Therapeutics (VTVT) going to split?
There is no upcoming split for vTv Therapeutics.
What sector and industry does vTv Therapeutics (VTVT) operate in?
vTv Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
vTv Therapeutics Stock (NASDAQ:VTVT), Quotes and News Summary
vTv Therapeutics Stock (NASDAQ: VTVT) stock price, news, charts, stock research, profile.
| Open0.430 | Close0.440 |
| Vol / Avg.48.830K / 167.289K | Mkt Cap35.861M |
| Day Range0.410 - 0.463 | 52 Wk Range0.405 - 1.050 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.070 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-03-07 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 6.00 |
| 2022-08-17 | Northland Capital Markets | Carl Byrnes | Maintains | Outperform | Raises | 1.50 | 2.00 |
| 2022-02-18 | Cantor Fitzgerald | Charles Duncan | Initiates Coverage On | Overweight | Announces | - | 5.00 |
| 2020-02-10 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Raises | 5.00 | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| VTVT | vTv Therapeutics | 2.61% | 35.9M |
| CNTB | Connect Biopharma Hldgs | 11.66% | 40.1M |
| PHXM | PHAXIAM Therapeutics | -8.6% | 30M |
| ALGS | Aligos Therapeutics | -4.28% | 33.1M |
| NCNA | NuCana | 0% | 32.5M |
How do I buy vTv Therapeutics (VTVT) stock?
You can purchase shares of vTv Therapeutics (NASDAQ: VTVT) through any online brokerage.
Who are vTv Therapeutics's (VTVT) competitors?
Other companies in vTv Therapeutics’s space includes: Connect Biopharma Hldgs (NASDAQ:CNTB), PHAXIAM Therapeutics (NASDAQ:PHXM), Aligos Therapeutics (NASDAQ:ALGS), NuCana (NASDAQ:NCNA) and Alaunos Therapeutics (NASDAQ:TCRT).
What is the target price for vTv Therapeutics (VTVT) stock?
The latest price target for vTv Therapeutics (NASDAQ: VTVT) was reported by HC Wainwright & Co. on Tuesday, March 7, 2023. The analyst firm set a price target for 6.00 expecting VTVT to rise to within 12 months (a possible 1263.33% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for vTv Therapeutics (VTVT)?
The stock price for vTv Therapeutics (NASDAQ: VTVT) is $0.4401 last updated September 22, 2023 at 7:59 PM UTC.
Does vTv Therapeutics (VTVT) pay a dividend?
There is no dividend information for vTv Therapeutics.
When is vTv Therapeutics (NASDAQ:VTVT) reporting earnings?
vTv Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is vTv Therapeutics (VTVT) going to split?
There is no upcoming split for vTv Therapeutics.
What sector and industry does vTv Therapeutics (VTVT) operate in?
vTv Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
vTv Therapeutics Stock (NASDAQ:VTVT), Quotes and News Summary
vTv Therapeutics Stock (NASDAQ: VTVT) stock price, news, charts, stock research, profile.
| Open0.430 | Close0.440 |
| Vol / Avg.48.830K / 167.289K | Mkt Cap35.861M |
| Day Range0.410 - 0.463 | 52 Wk Range0.405 - 1.050 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.070 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-03-07 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 6.00 |
| 2022-08-17 | Northland Capital Markets | Carl Byrnes | Maintains | Outperform | Raises | 1.50 | 2.00 |
| 2022-02-18 | Cantor Fitzgerald | Charles Duncan | Initiates Coverage On | Overweight | Announces | - | 5.00 |
| 2020-02-10 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Raises | 5.00 | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| VTVT | vTv Therapeutics | 2.61% | 35.9M |
| CNTB | Connect Biopharma Hldgs | 11.66% | 40.1M |
| PHXM | PHAXIAM Therapeutics | -8.6% | 30M |
| ALGS | Aligos Therapeutics | -4.28% | 33.1M |
| NCNA | NuCana | 0% | 32.5M |
How do I buy vTv Therapeutics (VTVT) stock?
You can purchase shares of vTv Therapeutics (NASDAQ: VTVT) through any online brokerage.
Who are vTv Therapeutics's (VTVT) competitors?
Other companies in vTv Therapeutics’s space includes: Connect Biopharma Hldgs (NASDAQ:CNTB), PHAXIAM Therapeutics (NASDAQ:PHXM), Aligos Therapeutics (NASDAQ:ALGS), NuCana (NASDAQ:NCNA) and Alaunos Therapeutics (NASDAQ:TCRT).
What is the target price for vTv Therapeutics (VTVT) stock?
The latest price target for vTv Therapeutics (NASDAQ: VTVT) was reported by HC Wainwright & Co. on Tuesday, March 7, 2023. The analyst firm set a price target for 6.00 expecting VTVT to rise to within 12 months (a possible 1263.33% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for vTv Therapeutics (VTVT)?
The stock price for vTv Therapeutics (NASDAQ: VTVT) is $0.4401 last updated September 22, 2023 at 7:59 PM UTC.
Does vTv Therapeutics (VTVT) pay a dividend?
There is no dividend information for vTv Therapeutics.
When is vTv Therapeutics (NASDAQ:VTVT) reporting earnings?
vTv Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is vTv Therapeutics (VTVT) going to split?
There is no upcoming split for vTv Therapeutics.
What sector and industry does vTv Therapeutics (VTVT) operate in?
vTv Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
vTv Therapeutics Stock (NASDAQ:VTVT), Quotes and News Summary
vTv Therapeutics Stock (NASDAQ: VTVT) stock price, news, charts, stock research, profile.
| Open0.430 | Close0.440 |
| Vol / Avg.48.830K / 167.289K | Mkt Cap35.861M |
| Day Range0.410 - 0.463 | 52 Wk Range0.405 - 1.050 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.070 | -0.070 | 0.0000 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-03-07 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Maintains | - | 6.00 |
| 2022-08-17 | Northland Capital Markets | Carl Byrnes | Maintains | Outperform | Raises | 1.50 | 2.00 |
| 2022-02-18 | Cantor Fitzgerald | Charles Duncan | Initiates Coverage On | Overweight | Announces | - | 5.00 |
| 2020-02-10 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | Buy | Raises | 5.00 | 6.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| VTVT | vTv Therapeutics | 2.61% | 35.9M |
| CNTB | Connect Biopharma Hldgs | 11.66% | 40.1M |
| PHXM | PHAXIAM Therapeutics | -8.6% | 30M |
| ALGS | Aligos Therapeutics | -4.28% | 33.1M |
| NCNA | NuCana | 0% | 32.5M |
How do I buy vTv Therapeutics (VTVT) stock?
You can purchase shares of vTv Therapeutics (NASDAQ: VTVT) through any online brokerage.
Who are vTv Therapeutics's (VTVT) competitors?
Other companies in vTv Therapeutics’s space includes: Connect Biopharma Hldgs (NASDAQ:CNTB), PHAXIAM Therapeutics (NASDAQ:PHXM), Aligos Therapeutics (NASDAQ:ALGS), NuCana (NASDAQ:NCNA) and Alaunos Therapeutics (NASDAQ:TCRT).
What is the target price for vTv Therapeutics (VTVT) stock?
The latest price target for vTv Therapeutics (NASDAQ: VTVT) was reported by HC Wainwright & Co. on Tuesday, March 7, 2023. The analyst firm set a price target for 6.00 expecting VTVT to rise to within 12 months (a possible 1263.33% upside). 1 analyst firms have reported ratings in the last year.
Current Stock Price for vTv Therapeutics (VTVT)?
The stock price for vTv Therapeutics (NASDAQ: VTVT) is $0.4401 last updated September 22, 2023 at 7:59 PM UTC.
Does vTv Therapeutics (VTVT) pay a dividend?
There is no dividend information for vTv Therapeutics.
When is vTv Therapeutics (NASDAQ:VTVT) reporting earnings?
vTv Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.
Is vTv Therapeutics (VTVT) going to split?
There is no upcoming split for vTv Therapeutics.
What sector and industry does vTv Therapeutics (VTVT) operate in?
vTv Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.